Drug Type Small molecule drug |
Synonyms XEL 1000 |
Target- |
Action modulators |
Mechanism Cell membrane modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cystic Fibrosis | Clinical | - | - | |
| Cystic Fibrosis | Clinical | - | - | |
| Pseudomonas Infections | Clinical | - | - | |
| Pseudomonas Infections | Clinical | - | - | |
| Respiratory Tract Infections | Clinical | Norway | - |





